News
Study finds big growth in advanced-practice clinicians in Medicare dermatology
PAs and NPs can fill practice gaps, but some express concerns about lack of certification, supervision, and training.
News
Harvard medical school sued over stolen body part scandal
The indictment alleges that from 2018 through August 2022, Harvard morgue manager Cedric Lodge stole dissected portions of donated cadavers,...
News
Did ob.gyn. residencies take a hit from abortion bans?
“If you’re somewhere that you can’t really provide full-spectrum reproductive health care ... How is the program going to provide that training?”...
News
Low-dose oral minoxidil for hair loss soars after NYT article
Dermatologists are increasingly familiar with the medication, but a popular media report seems to have resulted in a quick uptake.
News
Scientists discover variants, therapy for disabling pansclerotic morphea
The JAK inhibitor ruxolitinib dramatically improved wound healing and rashes in patients with the very rare disorder.
News
FDA OKs first-ever topical gene therapy, for rare skin disease
“Because it’s safe and easy to apply directly to wounds, it doesn’t require a lot of supporting technology or specialized expertise, making...
News
New guidance on neurological complications of long COVID
The most common neurological symptoms are headache, weakness, muscular pain, nerve pain, tremors, peripheral nerve issues, sleep issues, and...
News
CDC backs FDA’s call for second COVID booster for those at high risk
The agency is following the recommendations made by its Advisory Committee on Immunization Practices (ACIP).
News
Tranq-contaminated fentanyl now in 48 states, DEA warns
Xylazine was first approved by the FDA in 1972 as a sedative and analgesic for use only in animals, but is increasingly being detected in illicit...
News
FDA approves OTC naloxone, but will cost be a barrier?
“The major question is what is it going to cost. In order for people to access it they have to be able to afford it,”
News
FDA moves to stop the spread of illicit ‘tranq’ in the U.S.
The agency “remains concerned about the increasing prevalence of xylazine mixed with illicit drugs,” said FDA Commissioner Robert M. Califf, MD....
News
DEA proposals on telehealth for controlled substances draw fire
Both proposals would allow providers to prescribe a 30-day supply of a controlled substance or buprenorphine, but then require a face-to-face...
News
Physician pleads guilty to 52 counts in opioid scheme
The neuromuscular medicine specialist also admitted to ignoring patient requests to lower dosages and signs that patients were selling prescribed...
News
Feds charge 25 nursing school execs, staff in fake diploma scheme
The purchasers in the diploma scheme paid $10,000 to $15,000 for degrees and transcripts.
News
Concern grows over ‘medical assistance in dying for mental illness’ law
With the addition of serious mental illness as an eligible category, Canada is on track to have the most liberal assisted-death policy in the...